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Abstract
Key steps in mRNA export are the nuclear assembly of messenger ribonucleoprotein particles 
(mRNPs), the translocation of mRNPs through the nuclear pore complex (NPC), and the mRNP 
remodeling events at the cytoplasmic side of the NPC. Nup358/RanBP2 is a constituent of the 
cytoplasmic filaments of the NPC specific to higher eukaryotes and provides a multitude of 
binding sites for the nucleocytoplasmic transport machinery. Here, we present the crystal structure 
of the Nup358 N-terminal domain (NTD) at 0.95-Å resolution. The structure reveals an α-helical 
domain that harbors three central tetratricopeptide repeats (TPR), flanked on each side by an 
additional solvating amphipathic α helix. Overall, the NTD adopts an unusual extended 
conformation that lacks the characteristic peptide-binding groove observed in canonical TPR 
domains. Strikingly, the vast majority of the NTD surface exhibits an evolutionarily conserved, 
positive electrostatic potential, and we demonstrate that the NTD possesses the capability to bind 
single-stranded RNA in solution. Together, these data suggest that the NTD contributes to mRNP 
remodeling events at the cytoplasmic face of the NPC.
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Introduction
The bidirectional transport of macromolecules between the nucleus and cytoplasm is 
mediated solely by nuclear pore complexes (NPCs). NPCs are composed of ≈30 different 
proteins termed nucleoporins (nups) and are among the largest proteinaceous assemblies in 
the eukaryotic cell (≈60 MDa in yeast, ≈120 MDa in vertebrates).1 In addition to its central 
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role in nucleocytoplasmic transport, the NPC has various other important functions, such as 
chromatin organization, regulation of transcription, and DNA repair.1
NPCs consist of a doughnut-shaped symmetric core that is decorated asymmetrically by 
nups that form the cytoplasmic filaments and a nuclear “basket” structure.1 Structural 
studies have established an evolutionary connection between the symmetric core of the NPC 
and membrane coats.2-7 The cytoplasmic filaments provide the binding sites for transport-
factor•cargo complexes and are composed of four proteins in vertebrates, CG1, Nup88, 
Nup214/CAN, and Nup358/RANBP2.1,8 Nup358 has no obvious homolog in yeast and is a 
unique component of NPCs of higher eukaryotes.9,10
Over the last decade, key steps in the export of mRNA from the nucleus to the cytoplasm 
have been identified and linked to the cytoplasmic filament nups.8,11 Nup88 is required for 
the recruitment of Nup98, an essential component of the export complexes of both ribosomal 
and messenger RNAs.12-15 Nup214/CAN binds the DEAD-box helicase Ddx19/hDbp5, an 
mRNA export factor that is involved in mRNP remodeling events at the cytoplasmic face of 
the NPC.16-18 Nup358 provides binding sites for not only the heterodimeric mRNA export 
receptor NXF1•p1519, but also SUMOylated RanGAP1 and the export factor CRM1.20,21 In 
addition to its function in nucleocytoplasmic transport, Nup358 relocates to the kinetochore 
during mitosis and plays various other crucial roles during mitosis, such as facilitating 
spindle formation and chromosome congression and segregation.22,23
A striking link exists between the nups that constitute or interact with the cytoplasmic 
filaments and neoplastic disease.24,25 Chromosomal translocations involving Nup98 have 
been identified in patients with acute myelogenous leukemia, myelodysplastic syndrome, 
chronic myelogenous leukemia, and T cell acute lymphoblastic leukemia.24 Expression of 
Nup88 is strongly upregulated in late-stage breast cancer and is used as a prognostic 
marker.26 Similarly, the expression of Nup214/CAN and Nup358 is upregulated in plasma 
cells from patients with multiple myeloma, emphasizing the importance of these nups in 
tumorigenesis. 27 Fusions of Nup214/CAN and Nup358 are involved in leukemogenesis, 
particularly acute myelogenous leukemia.28,29 Moreover, mutations in Nup358 have been 
linked to the susceptibility of otherwise healthy children to acute necrotizing encephalopathy 
following common viral infections, such as influenza.30
The polypeptide chain of Nup358 contains 3,224 residues and can approximately be divided 
into several distinct regions: an N-terminal ~830-residue α-helical region followed by four 
RanGTP-binding domains, eight consecutive zinc finger motifs, an E3 ligase domain, and a 
C-terminal cyclophilin A homology domain (Fig. 1a).9,10 These domains are connected by 
predicted unstructured regions containing phenylalanine-glycine (FG) repeats, which 
constitute the docking sites for mobile transport factors.1,11,31 So far only small fragments, 
the E3 ligase domain and two Ran binding domains, of Nup358 have been structurally 
characterized.
In order to deepen our understanding of the structural organization of Nup358, we have 
determined the crystal structure of the N-terminal domain (NTD) of Nup358 at 0.95-Å 
resolution. The structure reveals an α-helical domain with the overall shape of an extended 
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sheet with a right-handed twist that is primarily composed of three non-canonical 
tetratricopeptide repeats (TPRs). Strikingly, the surface of Nup358NTD is highly positively 
charged and we demonstrate biochemically that it binds to single-stranded RNA. We show 
that Nup358NTD is not required for nuclear envelope localization of Nup358 in vivo. These 
results suggest that Nup358NTD plays a role in RNA export events that occur at the 
cytoplasmic face of the NPC.
Results
Structure determination
We designed a series of expression constructs for the approximately 830-residue N-terminal 
region of human Nup358, which is predicted to be entirely α-helical. We identified a stable 
fragment consisting of residues 1 to 145, which we termed the Nup358 N-terminal domain 
(Nup358NTD) (Fig. 1a). Crystals of the human Nup358NTD were non-merohedrally twinned, 
preventing experimental phasing efforts. To overcome the inherent twinning of the crystals, 
we purified the NTDs of various homologous species. The Pan troglodytes Nup358NTD is 
monomeric in solution with a molecular mass of 17.4 kDa (theoretical 17.1 kDa), as 
determined by size-exclusion chromatography coupled with multiangle light scattering (Fig. 
1b). Crystals of P. troglodytes Nup358NTD belong to the orthorhombic space group P21212 
with one molecule in the asymmetric unit, and yielded diffraction data with only a small 
twinning fraction. The structure of P. troglodytes Nup358NTD was solved by single-
wavelength anomalous dispersion (SAD) using X-ray diffraction data collected from crystals 
of a selenomethionine-labeled mutant in which three additional methionines were 
incorporated with the aid of a multi-species sequence alignment (Fig. 2). The structure of P. 
troglodytes Nup358NTD was refined to 0.95-Å resolution with Rwork and Rfree values of 
18.2 % and 20.9 %, respectively. Moreover, we were able to solve the structure of the human 
Nup358NTD by molecular replacement using the P. troglodytes Nup358NTD as the search 
model and refined the structure to 1.15 Å resolution with Rwork and Rfree values of 23.6 % 
and 25.6 %, respectively. For details of the data collection and refinement statistics, see 
Table 1. The structures of the P. troglodytes and human Nup358NTD adopt the same fold and 
align with a root-mean square deviation (RMSD) of 0.27 Å over all atoms. Due to the higher 
quality of the data, we will focus our structural analysis on the P. troglodytes Nup358NTD.
Architectural overview and topology
The polypeptide chain of Nup358NTD folds into a slightly curved, right-handed twisted sheet 
with approximate dimensions of 55 Å × 20 Å × 25 Å, which consists of eight α-helices, αA-
αH, that are stacked in a zigzag arrangement (Fig. 3a and Fig. S1). The majority of the 
domain is formed by three central tetratricopeptide repeats (TPRs), αB-αC (TPR1), αD-αE 
(TPR2), and αF-αG (TPR3), that are arranged in tandem and are capped at the N- and C-
terminal ends by additional solvating amphipathic αhelices (αA and αH) (Fig. 3a, b). The 
eight αhelices of the domain segregate into inner (αB, αD, αF, and αH) and outer (αA, αC, 
αE, and αG) layers, which dominate the concave and convex surfaces, respectively (Fig. 3 
and Fig. 4a). Overall, Nup358NTD displays an unusual, elongated topology with a right-
handed twist of ≈80° between the first α helix (αA) and last α helix (αH), resulting in a 
substantially shallower surface groove compared to canonical TPR proteins (see below).
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TPRs of the Nup358NTD
The canonical TPR motif consists of ≈34 residues that fold into a pair of anti-parallel 
αhelices.32 While the TPR sequence motif is degenerate in nature, a conserved pattern of 
small and large hydrophobic signature residues with the consensus sequence 
W4G8Y11G15Y17A20Y24A27P32 can be identified33. These residues form a network of 
packing interactions between and within TPR repeats. Canonical TPR proteins contain 3-16 
TPRs arranged in tandem. Adjacent αhelices are typically rotated counterclockwise with an 
angle of 24°. As a consequence of this regular stacking, the α helices adopt a right-handed 
super-helical conformation.
The Nup358NTD core is composed of three TPRs that superimpose with an RMSD of ≈1.2 
Å over 34 Cα atoms (Fig. 5). This TPR core is capped by additional N- and C-terminal 
amphipathic αhelices, αA and αH. These solvating αhelices cover the terminal hydrophobic 
residues of TPR1 and TPR3 and expose polar residues to the outside of the domain. Notably, 
the angles between α helices of the same TPR and between adjacent TPRs both differ 
markedly from the canonical ≈24° angle:32 the angles between αA-αB (16°), αB-αC (15°), 
αD-αE (18°), and αE-αF (20°) are smaller, and those between αC-αD (28°), αF-αG (34°), 
and αG-αH (30°) are larger. This deviation results in the unusual elongated and twisted 
topology of the Nup358 NTD instead of the regular right-handed solenoid conformation 
observed in canonical TPR proteins.32
Despite the atypical inter-helical angles, the interactions within the three Nup358NTD TPRs 
are mediated mostly by canonical interactions. Similarly, the contacts between the solvating 
αhelices and their neighboring TPRs are mediated via interactions that resemble those 
between canonical TPRs. A marked exception to the canonical motif can be found at 
position 27 in TPR1, where a small, hydrophobic residue is highly conserved in TPRs due to 
steric restrictions. However, instead of this small residue, a large hydrophobic residue, 
Tyr52, can be found in TPR1, inducing a sharp ≈40° kink in the neighboring αhelix, αB. A 
multi-species sequence alignment reveals that this tyrosine is highly conserved throughout 
evolution at this position in Nup358NTD (Fig. 2).
Surface properties
To identify potential protein-protein interaction sites, we analyzed the conservation and the 
electrostatic potential of the Nup358NTD surface (Fig. 6a, b). With the exception of the N-
terminal solvating helix αA whose residues are more variable across species, the surface of 
the Nup358NTD is highly conserved within higher eukaryotes (Fig. 2). Most of the conserved 
residues in the three TPRs coincide with TPR signature residues, with the exception of 
Tyr52 in TPR1, which induces the kink in helix αB (Fig 4a, b). Strikingly, analysis of the 
electrostatic properties of Nup358NTD reveals that the majority of the surface possesses a 
highly positive surface potential, while only one side of the molecule is negatively charged, 
resulting in a segregation of opposing potentials. In addition, two small and essentially 
invariant hydrophobic regions can be identified on the concave surface of the C-terminal half 
and on the central elevation of the convex surface. The distinct, positive surface potential is 
the result of an unusually high and evolutionarily-conserved Lys/Arg content (≈20 %) that 
dominates the surface properties of the molecule (Fig. 2 and Fig. 6). The small surface patch 
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of negative surface potential is generated exclusively by the solvating, C-terminal helix αH 
and the intra-repeat loops of the three TPRs (Fig. 6b). Notably, the high content of positively 
charged residues does not extend to the α-helical region that follows Nup358NTD, 
supporting the conclusion that the entire N-terminal α-helical region of Nup358 is 
composed of at least two domains with distinct functions.
Structural comparison
To investigate whether Nup358NTD may be suitable to mediate interactions with short, yet 
extended peptide fragments as previously described for other TPR proteins, we compared 
the structure of Nup358NTD to those of protein phosphatase 5 (PP5),34 the TPR1 domain of 
Hop in complex with an Hsp70 peptide,35 and the superhelical TPR domain of O-linked 
GlcNAc transferase (OGT)36 (Fig. 7). PP5 and Hop contain TPR domains that are of similar 
size to Nup358NTD, while OGT is constructed of 11.5 TPRs.
The TPR domain of PP5 consists of three virtually identical, canonical TPR motifs that 
exhibit a right-handed superhelical conformation with an amphipathic channel at its concave 
surface that was shown to bind short, extended peptide fragments.34 Hop mediates the 
association between Hsp70 and Hsp90 via C-terminal peptides containing an EEVD motif. 
Peptide recognition involves the two-carboxylate moieties at the C-terminus of the peptide 
and conserved lysines and asparagines in all three TPRs that protrude from the concave 
surface of the domain.35 The superhelical TPR domain of OGT has been proposed to 
recognize substrate proteins via a concave surface lined by invariant asparagines, the most 
common residues at positions 6 and 9 in many TPR proteins36 (Fig. 5b).
In contrast to these TPR proteins, Nup358NTD exhibits not only a markedly different 
topology of an open, extended, sheet-like conformation instead of the typical peptide-
binding cradle, but it also lacks the canonical residues that are required for peptide 
recognition (Fig. 5b). Hence, Nup358NTD appears poorly suited for binding extended 
peptide fragments in a carboxylate-clamp like fashion.
Nup358NTD binds to RNA in vitro
Nup358NTD is not the only nucleoporin with an evolutionarily conserved strongly positive 
surface potential. Previously, we have shown that the Rae1•Nup98GLEBS nucleoporin pair, 
another component of the cytoplasmic filaments of the NPC, possesses similar surface 
properties and is capable of binding single-stranded RNA in vitro.37 During the purification 
of Nup358NTD, we noticed the co-purification of endogenous bacterial RNA, as 
demonstrated by a digestion assay employing several DNA and RNA nucleases (Fig. 8a). 
Therefore, we analyzed whether Nup358NTD is able to bind to a fluorescently labeled, 
decameric, degenerate, single-stranded RNA oligonucleotide using fluorescence anisotropy 
binding measurements. Indeed, we found that Nup358NTD directly binds to single-stranded 
RNA with an apparent dissociation constant of 264±45 μM in the presence of 5 mM MgCl2 
(Fig. 8b). Together, these data indicate that Nup358NTD possesses weak binding affinity for 
single-stranded RNA that is not solely explained by electrostatics.
Kassube et al. Page 5
J Mol Biol. Author manuscript; available in PMC 2014 November 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In vivo analysis
Nup358 is part of a nucleoporin subset that relocates to kinetochores after nuclear envelope 
breakdown.23 During interphase, Nup358 localizes to the cytoplasmic face of the NPC.9,10 
To investigate whether the Nup358 NTD is required for NPC localization of Nup358, we 
analyzed the localization of a series of HA-tagged Nup358 constructs in HEK293T cells 
(Fig. 9). We found that full-length Nup358 and a Nup358 fragment that lacks the NTD 
(Nup358ΔNTD) yield nuclear envelope rim staining that coincides with staining by mAb414, 
an antibody that recognizes a group of FG-repeat containing nucleoporins.38 In contrast, a 
Nup358 fragment that encompasses only the NTD is dispersed throughout the cell and does 
not enrich at the nuclear envelope. We conclude that the NTD is not required for nuclear 
envelope localization and dispensable for Nup358 anchoring to the cytoplasmic face of the 
NPC.
Conclusions
The N-terminal domain of Nup358 is composed of three central TPRs that are capped on 
both ends by solvating amphipathic αhelices. In contrast to other TPR domains, Nup358NTD 
adopts an unusual extended, twisted sheet conformation with an evolutionarily conserved, 
highly positive surface potential that is incompatible with the canonical carboxylate-clamp 
mediated binding of short peptides, but facilitates the weak association with single-stranded 
RNA oligonucleotides. In vivo, the NTD is dispensable for nuclear envelope localization of 
Nup358.
What may be the physiological significance of the RNA binding property of Nup358NTD? 
Nup358 is localized at the cytoplasmic face of the NPC, in close proximity to Nup214, and 
Nup88. Together, these two cytoplasmic filament nucleoporins play essential roles in the 
nuclear export of mRNA by providing critical binding platforms for several components of 
the mRNA export machinery, thereby recruiting them to the cytoplasmic face of the NPC. 
Specifically, Nup88 recruits the Nup98•Rae1 complex, which also possesses weak single-
stranded RNA binding activity, and Nup214 recruits the DEAD-box helicase Ddx19 and its 
ATPase-activating protein Gle1.14,17,18,37,39 The co-operation of Nup214 with Ddx19 and 
Gle1 has been proposed to result in the release of nuclear RNA binding proteins that cover 
the exported mRNA.8 Nup358 has been shown to provide a major binding site for the 
evolutionarily conserved mRNA export heterodimer p15•TAP at the cytoplasmic filaments 
of the NPC.19 Therefore, Nup358NTD may be uniquely positioned to transiently interact and 
concentrate mRNPs at the cytoplasmic face of the NPC to speed their disassembly by Dbp5 
or is involved in the export of other small RNA molecules, such as microRNPs, semi-
assembled snurps, or ribosomal subunits.
Materials and Methods
Protein expression and purification
The DNA fragment encoding the N-terminal domain of human and P. troglodytes Nup358 
(residues 1-145) was amplified by PCR and inserted into the pGEX-6P1 expression vector 
(GE Healthcare) using BamHI and NotI restriction sites. The vector fuses an N-terminal 
glutathione-S-transferase (GST)-tag to the protein with a PreScission protease cleavage site 
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directly after the GST-tag. Proteolytic cleavage leaves an additional five residues with the 
sequence GPLGS on the N terminus of Nup358NTD. Mutagenesis to produce the methionine 
mutants of P. troglodytes Nup358NTD, T27M, Y37M and T92M, was performed by 
Quikchange site-directed mutagenesis (Stratagene).
All Nup358 NTDs were expressed in E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene) 
that were grown in LB media containing appropriate antibiotics. Protein expression was 
induced at OD600 of ≈0.6 with 450 μM isopropyl-β-D-thiogalactoside at 18 °C for 14 hours. 
The cells were harvested by centrifugation and lysed with a cell disruptor (Avestin) in a 
buffer containing 20 mM TRIS, pH 8.0, 500 mM NaCl, 5 mM β-mercaptoethanol (β-ME), 
0.5 mM phenylmethylsulfonyl fluoride (Sigma), 2 μM bovine lung aprotinin (Sigma), and 
complete EDTA-free protease inhibitor cocktail (Roche). After centrifugation at 40,000 × g 
for 90 min, the supernatant was filtered through a 0.22 μm filter (Millipore), loaded onto a 
glutathione Sepharose 4B column (GE Healthcare) equilibrated in buffer A (20 mM TRIS, 
pH 8.0, 100 mM NaCl, 5 mM DTT), and eluted with a linear gradient of buffer B (buffer A 
supplemented with 20 mM glutathione). Protein-containing fractions were pooled and the 
GST-tag was cleaved with PreScission protease (GE Healthcare) during extensive dialysis 
against buffer A for 14 hours. The sample was then loaded onto a glutathione Sepharose 4B 
column to remove uncleaved protein, free GST, and GST-PreScission, and cleaved protein 
was collected in the flowthrough. After concentration, the protein was further purified by 
size exclusion chromatography on a Superdex 75 16/60 column (GE Healthcare) 
equilibrated in buffer A. Protein-containing fractions were pooled and concentrated to 10 
mg/ml for crystallization.
Seleno-L-methionine-labeled protein was produced in E. coli BL21-CodonPlus (DE3)-RIL 
cells (Stratagene) in a synthetic medium that suppresses methionine biosynthesis, following 
standard protocols.40
Crystallization and data collection
Initial crystals of Nup358NTD were grown at 4 °C in 2 μl hanging drops containing equal 
volumes of the protein solution and a reservoir solution consisting of 16-18 % (w/v) PEG 
3,350 and 200 mM lithium acetate. Large crystals were obtained by microseeding in 2.5 μl 
hanging drops containing an additional 0.5 μl seeding solution equilibrated against a 
reservoir solution consisting of 3-5 % (w/v) PEG 3,350 and 200 mM lithium acetate. 
Crystals appeared within hours and grew to a final size of approximately 1.0 × 1.5 × 1.0 
mm3 within a week. For cryoprotection, crystals were transferred in paraffin oil and flash 
frozen in liquid nitrogen. Native and anomalous X-ray diffraction data were collected at 100 
K at beamline 12-2 at the Stanford Synchrotron Radiation Lightsource (SSRL). X-ray 
intensities were processed with the HKL2000 denzo/scalepack package.41
Structure determination and refinement
Phases were determined with SHARP,42 using X-ray diffraction data from crystals of a 
seleno-L-methionine-labeled P. troglodytes Nup358NTD mutant in which three additional 
methionine-residues were incorporated at positions 27, 37, and 92, followed by density 
modification in DM and Solomon (CCP4)43 with solvent flattening, histogram matching, 
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and NCS averaging. Iterative model building and refinement were carried out with the 
programs O,44 Coot,45 CNS,46 and PHENIX.47 The final model of the P. troglodytes 
Nup358NTD contains residues 2-145 and was refined to 0.95-Å resolution with Rwork and 
Rfree values of 18.2 % and 20.9 %, respectively. The structure of the human Nup358NTD was 
solved by molecular replacement in Phaser48, using the coordinates of the P. troglodytes 
Nup358NTD as the search model. The final model of the human Nup358NTD contains 
residues 3-145 and was refined to 1.15-Å resolution with Rwork and Rfree values of 23.6 % 
and 25.6 %, respectively. The crystals of human Nup358NTD are non-merohedrally twinned 
with orthorhombic unit cell dimensions of a≈2c, and, thus, explain the higher R factors than 
expected for this resolution.49 The stereochemical quality of both models is excellent 
according to assessment with PROCHECK50 and MolProbity.51 For details of the data 
collection and refinement statistics, see Table 1.
Analytical size-exclusion chromatography
Analytical gel filtration experiments were carried out on a Superdex 200 10/300 GL gel 
filtration column (GE Healthcare) that was equilibrated in a buffer containing 20 mM TRIS, 
pH 8.0, 100 mM NaCl, and 5 mM DTT. 1 mg of the purified Nup358NTD was injected, and 
the elution volume monitored. Molecular weight standards (GE healthcare) were injected in 
identical buffer conditions and used for molecular mass determination.
Multiangle light scattering
Purified proteins were characterized by multi-angle light scattering following size exclusion 
chromatography.52 Protein at various concentrations (50-100 μM) was injected onto a 
Superdex 200 10/300 GL gel filtration chromatography column (GE Healthcare) 
equilibrated in a buffer containing 20 mM TRIS, pH 8.0, 100 mM NaCl, and 5 mM DTT. 
The chromatography system was connected in series with an 18-angle light scattering 
detector (DAWN HELEOS II, Wyatt Technology), a dynamic light scattering detector 
(DynaPro Nanostar, Wyatt Technology), and a refractive index detector (Optilab t-rEX, 
Wyatt Technology). Data was collected every 1 second at a flow rate of 0.5 mL/min at 
25 °C. Data analysis was carried out using the program ASTRA 6, yielding the molar mass 
and mass distribution (polydispersity) of the sample.
Nuclease digests
Nup358NTD•RNA complex was subjected to treatment with 1 unit each of DNase I (Roche), 
benzonase (VWR), RNase A (Qiagen), RNase T1 (Roche), and RNase V1 (Applied 
Biosystems), in a buffer containing 20 mM TRIS, pH 8.0, 100 mM NaCl, and 5 mM DTT 
for 30 min at room temperature. The reactions were then separated on a 1.2 % TRIS-acetate-
EDTA agarose gel and visualized by ethidium bromide staining.
Fluorescence anisotropy
Fluorescence anisotropy measurements were obtained using a Wallac 1420 Multilabel 
Counter plate reading instrument (Perkin Elmer) with a temperature controlled sample 
chamber at 25°C. All fluorescence studies were carried out in 20 μl volumes. Buffer 
conditions were 20 mM TRIS, pH 8.0, 50 mM KCl, 5 mM MgCl2, 2 mM DTT, 10% (v/v) 
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glycerol. Cy3-labeled degenerate, 10-mer RNA oligo-nucleotides at a final concentration of 
100 nM were incubated with varying concentrations (100 nM, 200 nM, 500 nM, 1 μM, 1.5 
μM, and 2 μM) of Nup358NTD. Raw data were fit using Prism 5.0 (GraphPad Software) with 
the non-linear equation for one site specific binding Y=(Bmax*X/(Kd+X))+background) 
where X is the Nup358NTD concentration, Y the change in anisotropy and Bmax the 
maximum change in anisotropy.
Immunofluorescence microscopy
For immunofluorescence, full-length Nup358 and Nup358 fragments (residues 1-3224, 
1-145, and 146-3224) were inserted into the pCMV-HA vector (Clontech) using SalI and 
NotI restriction sites. The resulting Nup358 fragments contain a C-terminal HA-tag. 
HEK293T cells were grown on poly-L-lysine coated slides (Sigma) until ~50 % confluency. 
Transfection was performed with TransIT-LT1 transfection reagent (Mirus) according to the 
manufacturer's instructions. After 48 hours, the medium was removed and cells were washed 
in phosphate buffered saline (PBS) and fixed in PBS, supplemented with 2 % (w/v) 
formaldehyde for 5 min at room temperature. After two washes with PBS, the cells were 
permeabilized with PBS containing 0.1 % (v/v) TritonX-100 (Sigma-Aldrich) for 10 minutes 
at room temperature. The cells were then washed in PBS and blocked in PBS supplemented 
with 10 % (v/v) Fetal Calf Serum (FCS) for 20 min at room temperature. For nuclear 
envelope staining, the cells were incubated with a 1:500 dilution of the monoclonal antibody 
mAb414 (Abcam) in PBS buffer, supplemented with 0.1 % (w/v) saponin and 10 % (v/v) 
FCS for 16 hours at 4 °C. Secondary antibody incubation was performed with a 1:3000 
dilution of Alexa Fluor 568-labeled goat anti mouse antibody (Invitrogen) in PBS, 
supplemented with 0.1 % (w/v) saponin and 10 % (v/v) FCS for 1 hour at room temperature, 
followed by three washes with PBS. For detection of the HA-tagged proteins, the cells were 
incubated with a monoclonal antibody anti-HA Fluor488 conjugate antibody (Invitrogen) for 
1 hour at room temperature, washed three times with PBS, and mounted onto coverslips with 
ProLong Gold Antifade reagent with DAPI (Invitrogen). Slides were examined with 
fluorescence microscopy on a Carl Zeiss AxioImagerZ.1 equipped with an AxioCamMRm 
camera.
Illustration and figures
The sequence alignment of Nup358NTD was generated using ClustalX53 and colored with 
Alscript.54 Figures were generated using PyMOL (www.pymol.org), the electrostatic 
potential was calculated with APBS,55 and the inter-helical crossover angles were calculated 
with the program MOLMOL.56
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
1. Crystal structure of the N-terminal TPR domain of Nup358 at atomic 
resolution
2. Nup358 N-terminal domain possesses single-stranded RNA binding 
capacity
3. Nup358 N-terminal domain is dispensable for Nup358 nuclear 
envelope localization
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Fig. 1. 
Biochemical and biophysical analysis of Nup358NTD. (a) Domain organization of human 
Nup358. Domain boundaries are indicated by residue numbers. The bar above the domain 
structure denotes the crystallized fragment. I, II, III, and IV, Ran binding domains; NTD, N-
terminal domain; CycH, cyclophilin homology domain; E3, E3 ligase domain. (b) 
Multiangle light-scattering (MALS) analysis of the P. troglodytes Nup358NTD. The 
differential refractive index is plotted against the elution volumes from a Superdex 200 
10/300 GL gel-filtration column and is overlaid with the determined molecular mass.
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Fig. 2. 
Multi-species sequence alignment of Nup358NTD. The overall sequence conservation is 
shaded from white (less than 60 % similarity) to red (100 % identity) and has been 
calculated based on the Blosum62 algorithm. The secondary structure as observed in 
Nup358NTD structure is shown above the alignment, with blue bars representing α helices. 
The numbering below the sequence is relative to human Nup358. The positions of the 
introduced methinonine mutants and Y52 are indicated by green and purple dots, 
respectively.
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Fig. 3. 
Structure of the NTD of Nup358. (a) Ribbon representation of Nup358NTD shown in 
rainbow colors from the N- to the C-terminus (αA to αH). Views rotated by 90°, 180°, and 
270° are shown on the right. (b) Schematic drawing showing the structural organization of 
Nup358NTD. The α helices of the three centrally positioned TPR repeats form two layers, 
one on the concave (αB, αD, and αF) and one on the convex side (αC, αE, and αG) of the 
domain. The TPRs are capped by solvating α helices on both termini. (c) Representative 
final 2|fo|-|fc| electron density maps, rendered at 5.0 σ.
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Fig. 4. 
The non-canonical conformation of Nup358NTD is induced by bulky hydrophobic side 
chains. (a) Cartoon representation of Nup358NTD with selected side chains shown in ball 
and stick. A 90°-rotated view is shown on the right. (b) Helical wheel representation of the 
Nup358NTD with selected hydrophobic side chains drawn. The star denotes the position of 
the conserved Tyr52 in helix αC that induces the kink in helix αB.
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Fig. 5. 
The TPR motif of Nup358NTD. (a) Superposition of the three TPRs of Nup358NTD. The 
positions of the Cα atoms are shown as blue spheres. A 90°-rotated view is shown on the 
right. The three TPRs align well with the exception of the kinked α helix αB of TPR1, and 
the αF-αG loop of TPR3, which is one residue longer than in a canonical TPR. (b) 
Structure-based sequence alignment of the three TPRs and the two solvating α helices. The 
sequence of the consensus TPR is shown at the bottom of the alignment and is based on the 
analysis by Main and coworkers.57 The position of the α helices and the connecting loops 
relative to the consensus sequence is indicated at the top. Conserved small and large 
hydrophobic residues are highlighted with grey bars; large hydrophobic side chains are 
highlighted in orange.
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Fig. 6. 
Surface properties of Nup358NTD. (a) Surface representation illustrating the surface 
conservation. The surface is colored according to a multi-species sequence alignment (Fig. 
2). The conservation at each position is mapped onto the surface and is shaded in a color 
gradient from white (60 % similarity) to red (100 % identity). (b) Surface rendition colored 
according to the electrostatic potential from -5 kBT/e (red) to +5 kBT/e (blue). Black lines 
indicate the borders of the two evolutionarily conserved hydrophobic patches.
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Fig. 7. 
Comparison of Nup358NTD to other TPR proteins. The three central TPR repeats of (A) 
Nup358NTD, (B) the TPR1 domain of Hop in complex with an Hsp70 peptide (PDB code 
1ELW), (C) the TPR domain of protein phosphatase 5 (PDB code 1A17), and (D) the TPR 
domain of O-linked GlcNAc transferase (PDB code 1W3B) are illustrated. Equivalent TPRs 
are colored in orange. The Hsp70 peptide bound to the TPR1 domain of Hop is shown in 
yellow. Nup358NTD adopts a substantially shallower conformation as compared to the other 
TPR proteins.
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Fig. 8. 
Nup358NTD interacts with single-stranded RNA. (a) Nup358NTD co-purifies with E. coli 
RNA. Purified Nup358NTD•RNA was subjected to various DNA and RNA nuclease digests. 
(b) Association of Nup358NTD with fluorescently-labeled, single-stranded, degenerate, 
decameric RNA oligo-nucleotide. Fluorescence polarization reveals an apparent dissociation 
constant (Kd) of 264±45 μM between Nup358NTD and a Cy3-labeled degenerate, decameric, 
single-stranded RNA oligonucleotide. The mean of three experiments each measured three 
times are represented, error bars represent the SEM (standard error of the mean).
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Fig 9. 
In vivo localization of full-length Nup358 and Nup358 fragments. HEK293T cells were 
transfected with Nup358 and Nup358 fragments containing a C-terminal HA-tag and 
analyzed by fluorescence microscopy. The cellular localization of the HA-tagged Nup358 
proteins was detected with an α-HA antibody (green). The monoclonal α-mAb414 antibody 
(red) and DAPI (blue) were used as a reference for nuclear envelope and nucleus staining, 
respectively. The merged image is shown on the right.
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Table 1
Crystallographic Analysis
Pan troglodytes SeMet Pan troglodytes Native Homo sapiens Native
Data collection
Protein ptNup358NTD T27M Y37M T92M ptNup358NTD toNup358NTD
Synchrotron SSRLa SSRL SSRL
Beamline BL12-2 BL12-2 BL12-2
Space group P21212 P21212 P21212
Cell parameters
    a, b, c (Å) a=58.4, b=83.6, c=30.0 a=58.8, b=83.2, c=29.6 a=59.2, b=82.8, c=29.5
    α, β, γ (°) α=β=γ=90.0 α = β = γ = 90.0 α=β=γ=90.0
Se Peak
Wavelength (Å) 0.9795 0.7500 1.0332
Resolution (Å) 50.0 – 1.15 50.0 – 0.95 50.0 – 1.15
Rsym (%)b 6.7 (52.7) 6.5 (79.8) 4.5 (78.7)
</> / <σ/>b 21.9 (3.1) 35.2 (1.4) 60.5 (1.7)
Completeness (%)b 98.6 (93.1) 99.6 (98.7) 96.7 (76.6)
No. observations 2,054,575 5,334,428 2,304,141
No. unique reflections 99,589 (9,396) 91,707 (8,956) 50,873 (3,967)
Redundancy 6.3 (4.4) 12.2 (9.6) 15.6 (7.8)
Phasing power 2.093
Refinement
Resolution (Å) 50.0 – 1.15 50.0 – 0.95 50.0 – 1.15
No. reflections total 99,449 91,604 50,201
No. reflections test set 5,019 (5.05%) 4,588 (5.01%) 2,565 (5.11%)
Rwork / Rfree 19.3 / 22.3 17.7 / 19.9 21.4/ 23.9
No. atoms 2,650 3,299 2,854
    Protein 2,419 3,027 2,767
    Water 231 267 85
B-factors
    Protein 24.2 18.4 29.3
    Water 33.7 32.9 34.7
R.m.s. deviations
    Bond lengths (Å) 0.013 0.009 0.006
    Bond angles (°) 1.4 1.3 1.1
Ramachandran plotc
    Favored (%) 97.9 96.5 97.9
    Additionally allowed (%) 2.1 3.5 2.1
    Outliers (%) 0.0 0.0 0.0
MolProbity score 1.28 1.61 1.58
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aSSRL, Stanford Synchrotron Radiation Lightsource
b
Highest-resolution shell is shown in parentheses
cAs determined by MolProbity51
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